Cencora announced its agreement to acquire Retina Consultants of America from private equity firm Webster Equity Partners for approximately $4.6 billion in cash, marking a strategic move to enhance its physician and manufacturer relationships. Retina Consultants operates as a management services organization, comprising around 300 specialists across 23 states in the United States who provide care to patients, with more than 2 million visits conducted each year. Cencora's Chief Executive, Bob Mauch, emphasized the significance of this acquisition, stating, "Following our recent investment in OneOncology, the addition of Retina Consultants will allow us to expand our management services organization solutions." On the stock market, Cencora's shares experienced a notable uptick of 5.4% during the afternoon trading session. Robby Grabow, CEO of Retina Consultants, also shared insights on the impact of this transaction.
He said, "With additional resources to support the continued execution of our growth strategy, we will be better positioned to continue expanding our physician network and enhancing the quality of care we provide." Once this deal concludes, Cencora is set to secure approximately 85% ownership in Retina Consultants, while affiliated practices, physicians, and management will maintain a minority stake in the enterprise.
Cencora has outlined a potential payment of up to $500 million in its fiscal years 2027 and 2028, contingent on meeting specific targets. The company projects that this acquisition will contribute roughly $0.35 to its adjusted per-share earnings during the first 12 months, after accounting for estimated financing costs.
Additionally, Cencora recently disclosed that its fiscal fourth-quarter adjusted earnings per share jumped to $3.34, rising from $2.86 the previous year. Revenue also experienced a 15% increase to $79.05 billion, surpassing analyst expectations. For the fiscal year 2025, Cencora is projecting adjusted earnings per share between $14.80 and $15.10, compared to Wall Street's forecast of $14.77.
Moreover, the company anticipates adjusted revenue growth in the range of 7% to 9%. In light of its strong performance, Cencora's board of directors has decided to raise its quarterly dividend to $0.55 per share, up from $0.51, with distribution scheduled for November 29 to shareholders recorded by November 15..